» Articles » PMID: 36298513

Unravelling the Differential Host Immuno-Inflammatory Responses to and Infections in Sepsis

Overview
Date 2022 Oct 27
PMID 36298513
Authors
Affiliations
Soon will be listed here.
Abstract

Previous reports from our lab have documented dysregulated host inflammatory reactions in response to bacterial infections in sepsis. Both Gram-negative bacteria (GNB) and Gram-positive bacteria (GPB) play a significant role in the development and progression of sepsis by releasing several virulence factors. During sepsis, host cells produce a range of inflammatory responses including inducible nitric oxide synthase (iNOS) expression, nitrite generation, neutrophil extracellular traps (NETs) release, and pro-inflammatory cytokines production. The current study was conducted to discern the differences in host inflammatory reactions in response to both and along with the organ dysfunction parameters in patients of sepsis. We examined 60 ICU sepsis patients identified based on the Acute Physiology and Chronic Health Evaluation II (APACHE II) and Sequential Organ Failure Assessment (SOFA II) scores. Pathogen identification was carried out using culture-based methods and gene-specific primers by real-time polymerase chain reaction (RT-PCR). Samples of blood from healthy volunteers were spiked with (GNB) and (GPB). The incidence of NETs formation, iNOS expression, total nitrite content, and pro-inflammatory cytokine level was estimated. Prevalence of , (both GNB), , and (both GPB) was found in sepsis patients. Augmented levels of inflammatory mediators including expression, total nitrite, the incidence of NETs, and proinflammatory cytokines, during spiking, were found in response to infections in comparison with infections. These inflammatory mediators were found to be positively correlated with organ dysfunction in both GN and GP infections in sepsis patients. Augmented host inflammatory response was generated in infections as compared with .

Citing Articles

Light-activated nanoclusters with tunable ROS for wound infection treatment.

Wang X, Ding J, Chen X, Wang S, Chen Z, Chen Y Bioact Mater. 2024; 41:385-399.

PMID: 39184828 PMC: 11342113. DOI: 10.1016/j.bioactmat.2024.07.009.


Active myeloperoxidase: a promising biomarker to differentiate "acute" and "low-grade" peri-prosthetic joint infections from aseptic failures.

Maritati M, De Rito G, Rosta V, Cervellati C, Manfrinato M, Zanoli G Front Microbiol. 2024; 15:1417049.

PMID: 38912350 PMC: 11190362. DOI: 10.3389/fmicb.2024.1417049.


Novel evidence on sepsis-inducing pathogens: from laboratory to bedside.

Gatica S, Fuentes B, Rivera-Asin E, Ramirez-Cespedes P, Sepulveda-Alfaro J, Catalan E Front Microbiol. 2023; 14:1198200.

PMID: 37426029 PMC: 10327444. DOI: 10.3389/fmicb.2023.1198200.


ROS Production by a Single Neutrophil Cell and Neutrophil Population upon Bacterial Stimulation.

Pleskova S, Erofeev A, Vaneev A, Gorelkin P, Bobyk S, Kolmogorov V Biomedicines. 2023; 11(5).

PMID: 37239032 PMC: 10216488. DOI: 10.3390/biomedicines11051361.

References
1.
Gupta E, Gupta N, Kaushik S, Srivastava V, Kumar S, Mehta S . Functional role of iNOS-Rac2 interaction in neutrophil extracellular traps (NETs) induced cytotoxicity in sepsis. Clin Chim Acta. 2020; 513:43-49. DOI: 10.1016/j.cca.2020.12.004. View

2.
Kumar S, Gupta E, Kaushik S, Kumar Srivastava V, Mehta S, Jyoti A . Evaluation of oxidative stress and antioxidant status: Correlation with the severity of sepsis. Scand J Immunol. 2018; 87(4):e12653. DOI: 10.1111/sji.12653. View

3.
Danielski L, Giustina A, Bonfante S, Barichello T, Petronilho F . The NLRP3 Inflammasome and Its Role in Sepsis Development. Inflammation. 2019; 43(1):24-31. DOI: 10.1007/s10753-019-01124-9. View

4.
Black L, Puskarich M, Henson M, Miller T, Reddy S, Fernandez R . Quantitative and Qualitative Assessments of Cholesterol Association With Bacterial Infection Type in Sepsis and Septic Shock. J Intensive Care Med. 2020; 36(7):808-817. PMC: 8061684. DOI: 10.1177/0885066620931473. View

5.
Buhler T, Boos N, Leuppi-Taegtmeyer A, Berger C . Febrile illness and bicytopenia within hours after tick-borne encephalitis booster vaccination. NPJ Vaccines. 2019; 4:52. PMC: 6917779. DOI: 10.1038/s41541-019-0152-2. View